Vol. 1 - Issue 2:@0.743337:0.965677:0.857137:0.965677:0.857137:0.947594:0.743337:0.947594:0.011649:0.009239:0.005137:0.004620:0.004620:0.009239:0.004620:0.006153:0.004620:0.007188:0.007188:0.007188:0.010274:0.008205:0.004620:0.009239
45:@0.864761:0.971012:0.897116:0.971012:0.897116:0.940075:0.864761:0.940075:0.015815:0.016540
Research Publications:@0.663855:0.063855:0.886194:0.063855:0.886194:0.040840:0.663855:0.040840:0.016980:0.010442:0.009149:0.010442:0.011759:0.010014:0.010442:0.013076:0.005880:0.014370:0.013076:0.013076:0.006538:0.006538:0.010442:0.011759:0.007832:0.006538:0.011759:0.013076:0.009149
Effects of early adjunctive pharmacotherapy on serum levels :@0.123515:0.202664:0.884093:0.202664:0.884093:0.174036:0.123515:0.174036:0.020169:0.009041:0.009041:0.013426:0.013426:0.008406:0.011763:0.007560:0.015119:0.010069:0.007560:0.013426:0.015119:0.011763:0.008406:0.013426:0.007560:0.015119:0.015119:0.008406:0.016812:0.016812:0.013426:0.008406:0.008406:0.013426:0.013426:0.007560:0.015119:0.016812:0.015119:0.011763:0.023525:0.015119:0.013426:0.015119:0.008406:0.016812:0.013426:0.011763:0.015119:0.015119:0.013426:0.007560:0.015119:0.016812:0.007560:0.011763:0.013426:0.011763:0.016812:0.023525:0.007560:0.008406:0.013426:0.013426:0.013426:0.008406:0.011763:0.007560
of brain injury biomarkers in patients with traumatic brain :@0.132861:0.226420:0.874722:0.226420:0.874722:0.197792:0.132861:0.197792:0.015119:0.010069:0.007560:0.015119:0.011763:0.015119:0.008406:0.016812:0.007560:0.008406:0.016812:0.008406:0.016812:0.011763:0.013426:0.007560:0.015119:0.008406:0.015119:0.023525:0.015119:0.011763:0.015119:0.013426:0.011763:0.011763:0.007560:0.008406:0.016812:0.007560:0.015119:0.015119:0.008406:0.008406:0.013426:0.016812:0.008406:0.011763:0.007560:0.020169:0.008406:0.008406:0.016812:0.007560:0.008406:0.011763:0.015119:0.016812:0.023525:0.015119:0.008406:0.008406:0.013426:0.007560:0.015119:0.011763:0.015119:0.008406:0.016812:0.007560
injury: a systematic review of randomized controlled studies:@0.127775:0.250176:0.872296:0.250176:0.872296:0.221548:0.127775:0.221548:0.008406:0.016812:0.008406:0.016812:0.011763:0.013426:0.010069:0.007560:0.015119:0.007560:0.011763:0.013426:0.009948:0.009948:0.013426:0.023525:0.015119:0.008406:0.008406:0.013426:0.007560:0.011763:0.013426:0.013426:0.008406:0.013426:0.020169:0.007560:0.015119:0.010069:0.007560:0.011763:0.015119:0.016812:0.015119:0.015119:0.023525:0.008406:0.011763:0.013426:0.015119:0.007560:0.013426:0.015119:0.016812:0.008406:0.011763:0.015119:0.008406:0.008406:0.013426:0.015119:0.007560:0.009948:0.009948:0.016812:0.015119:0.008406:0.013426:0.011763
Noha O. Mansour:@0.104762:0.278756:0.293508:0.278756:0.293508:0.259029:0.104762:0.259029:0.014555:0.010079:0.011208:0.010079:0.021852:0.015683:0.005040:0.021852:0.019030:0.010079:0.011208:0.007842:0.010079:0.011208:0.008950
1:@0.293515:0.271886:0.299391:0.271886:0.299391:0.260693:0.293515:0.260693:0.005876
,  Mohamed  Hassan  systematically  searched  using  predefined :@0.299391:0.278457:0.900282:0.278457:0.900282:0.259258:0.299391:0.259258:0.005040:0.005040:0.016812:0.017921:0.010079:0.010079:0.008950:0.015683:0.008950:0.010079:0.005040:0.016806:0.014555:0.008950:0.007842:0.007842:0.008950:0.010079:0.005040:0.018774:0.007842:0.010079:0.006572:0.006572:0.008950:0.015683:0.008950:0.005604:0.005604:0.008950:0.008950:0.005604:0.005604:0.010079:0.005040:0.017951:0.007842:0.008950:0.008950:0.006713:0.008950:0.010079:0.008950:0.010079:0.005040:0.017963:0.010079:0.007842:0.005604:0.010079:0.010079:0.005040:0.017969:0.010079:0.006713:0.008950:0.010079:0.008950:0.005604:0.005604:0.010079:0.008950:0.010079:0.005040
Elnaem ,*,  Doaa  H.  Abdelaziz ,  Muna  search  terms.  English-language  randomized :@0.104762:0.295562:0.900298:0.295562:0.900298:0.276362:0.104762:0.276362:0.012317:0.005604:0.010079:0.008950:0.008950:0.015683:0.014675:0.005040:0.010079:0.005040:0.005040:0.016522:0.014555:0.010079:0.008950:0.008950:0.005040:0.016518:0.014555:0.005040:0.005040:0.015411:0.014555:0.010079:0.010079:0.008950:0.005604:0.008950:0.008950:0.005592:0.008950:0.005873:0.005040:0.005040:0.016522:0.017921:0.010079:0.010079:0.008950:0.005040:0.018769:0.007842:0.008950:0.008950:0.006713:0.008950:0.010079:0.005040:0.010222:0.005604:0.008950:0.006713:0.015683:0.007842:0.005040:0.005040:0.010227:0.012317:0.010079:0.010079:0.005604:0.005604:0.007842:0.010079:0.006713:0.005604:0.008950:0.010067:0.010079:0.010079:0.008950:0.010079:0.008950:0.005040:0.010220:0.006713:0.008950:0.010079:0.010079:0.010079:0.015683:0.005604:0.008950:0.008950:0.010079:0.005040
2,3:@0.166331:0.288990:0.181021:0.288990:0.181021:0.277797:0.166331:0.277797:0.005876:0.002938:0.005876
4:@0.408588:0.288990:0.414464:0.288990:0.414464:0.277797:0.408588:0.277797:0.005876
Barakat ,  Inderpal  Singh  Dehele ,  Mahmoud :@0.104762:0.312666:0.493139:0.312666:0.493139:0.293466:0.104762:0.293466:0.013446:0.008950:0.006713:0.008950:0.010079:0.008950:0.005604:0.014678:0.005040:0.005040:0.003923:0.006713:0.010079:0.010079:0.008950:0.006713:0.010079:0.008950:0.005604:0.005040:0.003911:0.011208:0.005604:0.010079:0.010079:0.010079:0.005040:0.003923:0.014555:0.008950:0.010079:0.008950:0.005604:0.008950:0.005867:0.005040:0.005040:0.003923:0.017921:0.008950:0.010079:0.015683:0.010079:0.010079:0.010079:0.005040
5,6:@0.167443:0.306095:0.182133:0.306095:0.182133:0.294901:0.167443:0.294901:0.005876:0.002938:0.005876
7:@0.385348:0.306095:0.391224:0.306095:0.391224:0.294901:0.385348:0.294901:0.005876
E.  Elrggal:@0.104762:0.329770:0.194488:0.329770:0.194488:0.310571:0.104762:0.310571:0.012317:0.005040:0.005040:0.008354:0.012317:0.005604:0.006342:0.010079:0.010079:0.008950:0.005604
8:@0.194482:0.323199:0.200358:0.323199:0.200358:0.312006:0.194482:0.312006:0.005876
,    and  Mahmoud  S.  Abdallah:@0.200358:0.329770:0.473400:0.329770:0.473400:0.310571:0.200358:0.310571:0.005040:0.005040:0.008356:0.005040:0.008358:0.008950:0.010079:0.010079:0.005040:0.008354:0.017921:0.008950:0.010079:0.015683:0.010079:0.010079:0.010079:0.005040:0.008358:0.011208:0.005040:0.005040:0.007247:0.014555:0.010079:0.010079:0.008950:0.005604:0.005604:0.008950:0.010079
9 :@0.473385:0.323199:0.482200:0.323199:0.482200:0.312006:0.473385:0.312006:0.005876:0.002938
1 :@0.104762:0.347037:0.113576:0.347037:0.113576:0.335844:0.104762:0.335844:0.005876:0.002938
Clinical  Pharmacy  and  Pharmacy  Practice :@0.118067:0.353609:0.493161:0.353609:0.493161:0.334409:0.118067:0.334409:0.013446:0.005604:0.005604:0.010079:0.005604:0.008950:0.008950:0.005604:0.005040:0.007701:0.011208:0.010079:0.008950:0.006713:0.015683:0.008950:0.008950:0.010079:0.005040:0.007691:0.008950:0.010079:0.010079:0.005040:0.007701:0.011208:0.010079:0.008950:0.006713:0.015683:0.008950:0.008950:0.010079:0.005040:0.007691:0.011208:0.006713:0.008950:0.008950:0.005604:0.005604:0.008950:0.008950:0.005040
Department,  Faculty  of  Pharmacy,  Mansoura :@0.104762:0.370713:0.493134:0.370713:0.493134:0.351513:0.104762:0.351513:0.014555:0.008950:0.010079:0.008950:0.006713:0.005604:0.015683:0.008950:0.010079:0.005604:0.005040:0.005040:0.005177:0.011208:0.008950:0.008950:0.010079:0.005604:0.005604:0.010079:0.005040:0.005183:0.010079:0.006713:0.005040:0.005193:0.011208:0.010079:0.008950:0.006713:0.015683:0.008950:0.008950:0.008761:0.005040:0.005040:0.005193:0.017921:0.008950:0.010079:0.007842:0.010079:0.010079:0.006713:0.008950:0.005040
University,  Mansoura,  Egypt.:@0.104762:0.387817:0.361400:0.387817:0.361400:0.368618:0.104762:0.368618:0.014555:0.010079:0.005604:0.010079:0.008950:0.006713:0.007842:0.005604:0.005604:0.008763:0.005040:0.005040:0.009436:0.017921:0.008950:0.010079:0.007842:0.010079:0.010079:0.006713:0.008950:0.005040:0.005040:0.009436:0.012317:0.010079:0.010079:0.010079:0.005604:0.005040
2:@0.104762:0.405085:0.110638:0.405085:0.110638:0.393891:0.104762:0.393891:0.005876
 School of Pharmaceutical Sciences, Universiti :@0.110638:0.411656:0.493144:0.411656:0.493144:0.392456:0.110638:0.392456:0.004846:0.011208:0.008950:0.010079:0.010079:0.010079:0.005604:0.004840:0.010079:0.006713:0.004846:0.011208:0.010079:0.008950:0.006713:0.015683:0.008950:0.008950:0.008950:0.010079:0.005604:0.005604:0.008950:0.008950:0.005576:0.004844:0.011208:0.008950:0.005604:0.008950:0.010079:0.008950:0.008950:0.007842:0.005040:0.004836:0.014555:0.010079:0.005604:0.010079:0.008950:0.006713:0.007842:0.005604:0.005604:0.005604:0.005040
Sains Malaysia, Minden, Malaysia.:@0.104762:0.428760:0.388470:0.428760:0.388470:0.409561:0.104762:0.409561:0.011208:0.008950:0.005604:0.010079:0.007842:0.004800:0.017921:0.008950:0.005604:0.008950:0.010079:0.007842:0.005604:0.008950:0.005040:0.004790:0.017921:0.005604:0.010079:0.010079:0.008950:0.010079:0.005040:0.004798:0.017921:0.008950:0.005604:0.008950:0.010079:0.007842:0.005604:0.008950:0.005040
3:@0.104762:0.446027:0.110638:0.446027:0.110638:0.434834:0.104762:0.434834:0.005876
  School  of  Pharmacy  and  Pharmaceutical :@0.110638:0.452599:0.493164:0.452599:0.493164:0.433399:0.110638:0.433399:0.005040:0.009102:0.011208:0.008950:0.010079:0.010079:0.010079:0.005604:0.005040:0.009098:0.010079:0.006713:0.005040:0.009102:0.011208:0.010079:0.008950:0.006713:0.015683:0.008950:0.008950:0.010079:0.005040:0.009092:0.008950:0.010079:0.010079:0.005040:0.009100:0.011208:0.010079:0.008950:0.006713:0.015683:0.008950:0.008950:0.008950:0.010079:0.005604:0.005604:0.008950:0.008950:0.005604:0.005040
Sciences, Ulster University, Coleraine, United :@0.104762:0.469703:0.493140:0.469703:0.493140:0.450503:0.104762:0.450503:0.011208:0.008950:0.005604:0.008950:0.010079:0.008950:0.008950:0.007842:0.005040:0.007914:0.014555:0.005604:0.006572:0.006572:0.008950:0.006713:0.007920:0.014555:0.010079:0.005604:0.010079:0.008950:0.006713:0.007842:0.005604:0.005604:0.008771:0.005040:0.007924:0.013446:0.010079:0.005604:0.008950:0.006713:0.008950:0.005604:0.010079:0.008950:0.005040:0.007908:0.014555:0.010079:0.005604:0.005604:0.008950:0.010079:0.005040
Kingdom,:@0.104762:0.486807:0.192714:0.486807:0.192714:0.467608:0.104762:0.467608:0.015522:0.006562:0.011047:0.011047:0.011047:0.011047:0.016641:0.005040
4:@0.104762:0.504075:0.110638:0.504075:0.110638:0.492881:0.104762:0.492881:0.005876
  Pharmacy  Practice  and  Clinical  Pharmacy :@0.110638:0.510646:0.493146:0.510646:0.493146:0.491446:0.110638:0.491446:0.005040:0.006640:0.011208:0.010079:0.008950:0.006713:0.015683:0.008950:0.008950:0.010079:0.005040:0.006634:0.011208:0.006713:0.008950:0.008950:0.005604:0.005604:0.008950:0.008950:0.005040:0.006624:0.008950:0.010079:0.010079:0.005040:0.006638:0.013446:0.005604:0.005604:0.010079:0.005604:0.008950:0.008950:0.005604:0.005040:0.006620:0.011208:0.010079:0.008950:0.006713:0.015683:0.008950:0.008950:0.010079:0.005040
Department,  Faculty  of  Pharmacy,  Future :@0.104762:0.527750:0.493138:0.527750:0.493138:0.508550:0.104762:0.508550:0.014555:0.008950:0.010079:0.008950:0.006713:0.005604:0.015683:0.008950:0.010079:0.005604:0.005040:0.005040:0.012174:0.011208:0.008950:0.008950:0.010079:0.005604:0.005604:0.010079:0.005040:0.012178:0.010079:0.006713:0.005040:0.012190:0.011208:0.010079:0.008950:0.006713:0.015683:0.008950:0.008950:0.008761:0.005040:0.005040:0.012188:0.011208:0.010079:0.005604:0.010079:0.006713:0.008950:0.005040
University in Egypt, Cairo, Egypt,   Department :@0.104762:0.544854:0.493149:0.544854:0.493149:0.525655:0.104762:0.525655:0.014555:0.010079:0.005604:0.010079:0.008950:0.006713:0.007842:0.005604:0.005604:0.010079:0.004211:0.005604:0.010079:0.004215:0.012317:0.010079:0.010079:0.010079:0.005604:0.005040:0.004211:0.013446:0.008950:0.005604:0.006713:0.010079:0.005040:0.004213:0.012317:0.010079:0.010079:0.010079:0.005604:0.005040:0.005040:0.005047:0.004217:0.014555:0.008950:0.010079:0.008950:0.006713:0.005604:0.015683:0.008950:0.010079:0.005604:0.005040
5:@0.382847:0.538283:0.388723:0.538283:0.388723:0.527090:0.382847:0.527090:0.005876
of  Clinical  Pharmacy  and  Therapeutics, :@0.104762:0.561959:0.493154:0.561959:0.493154:0.542759:0.104762:0.542759:0.010079:0.006713:0.005040:0.016018:0.013446:0.005604:0.005604:0.010079:0.005604:0.008950:0.008950:0.005604:0.005040:0.015998:0.011208:0.010079:0.008950:0.006713:0.015683:0.008950:0.008950:0.010079:0.005040:0.016008:0.008950:0.010079:0.010079:0.005040:0.015651:0.012317:0.010079:0.008950:0.006713:0.008950:0.010079:0.008950:0.010079:0.005604:0.005604:0.008950:0.007842:0.005040:0.005040
Faculty of Pharmacy, Applied Science Private :@0.104762:0.579063:0.493142:0.579063:0.493142:0.559864:0.104762:0.559864:0.011208:0.008950:0.008950:0.010079:0.005604:0.005604:0.010079:0.007616:0.010079:0.006713:0.007624:0.011208:0.010079:0.008950:0.006713:0.015683:0.008950:0.008950:0.008761:0.005040:0.006513:0.014555:0.010079:0.010079:0.005604:0.005604:0.008950:0.010079:0.007616:0.011208:0.008950:0.005604:0.008950:0.010079:0.008950:0.008950:0.007612:0.011208:0.006713:0.005604:0.010079:0.008950:0.005604:0.008950:0.005040
University, Amman,  Jordan, :@0.104762:0.596168:0.343209:0.596168:0.343209:0.576968:0.104762:0.576968:0.014555:0.010079:0.005604:0.010079:0.008950:0.006713:0.007842:0.005604:0.005604:0.008763:0.005040:0.007348:0.014555:0.015683:0.015683:0.008950:0.010079:0.005040:0.005040:0.003413:0.007842:0.010079:0.006713:0.010079:0.008950:0.010079:0.005040:0.005040
6:@0.346631:0.589596:0.352507:0.589596:0.352507:0.578403:0.346631:0.578403:0.005876
 MEU Research :@0.352507:0.596168:0.493154:0.596168:0.493154:0.576968:0.352507:0.576968:0.008467:0.017921:0.012317:0.014555:0.008467:0.013446:0.008950:0.007842:0.008950:0.008950:0.006713:0.008950:0.010079:0.005040
Unit, Middle East University, Amman, Jordan, :@0.104762:0.613272:0.482679:0.613272:0.482679:0.594072:0.104762:0.594072:0.014555:0.010079:0.005604:0.005604:0.005040:0.004570:0.017921:0.005604:0.010079:0.010079:0.005604:0.008950:0.004564:0.012317:0.008950:0.006572:0.006572:0.004576:0.014555:0.010079:0.005604:0.010079:0.008950:0.006713:0.007842:0.005604:0.005604:0.008763:0.005040:0.003461:0.014555:0.015683:0.015683:0.008950:0.010079:0.005040:0.004568:0.007842:0.010079:0.006713:0.010079:0.008950:0.010079:0.005040:0.005040
7:@0.482219:0.606701:0.488095:0.606701:0.488095:0.595507:0.482219:0.595507:0.005876
 :@0.488095:0.613272:0.493135:0.613272:0.493135:0.594072:0.488095:0.594072:0.005040
School of Pharmacy, University of Birmingham, :@0.104762:0.630376:0.493152:0.630376:0.493152:0.611177:0.104762:0.611177:0.011208:0.008950:0.010079:0.010079:0.010079:0.005604:0.003469:0.010079:0.006713:0.003473:0.011208:0.010079:0.008950:0.006713:0.015683:0.008950:0.008950:0.008761:0.005040:0.003473:0.014555:0.010079:0.005604:0.010079:0.008950:0.006713:0.007842:0.005604:0.005604:0.010079:0.003467:0.010079:0.006713:0.003473:0.013446:0.005604:0.006713:0.015683:0.005604:0.010079:0.010079:0.010079:0.008950:0.015683:0.005040:0.005040
Birmingham,  United  Kingdom, :@0.104762:0.647481:0.388687:0.647481:0.388687:0.628281:0.104762:0.628281:0.013446:0.005604:0.006713:0.015683:0.005604:0.010079:0.010079:0.010079:0.008950:0.015683:0.005040:0.005040:0.012881:0.014555:0.010079:0.005604:0.005604:0.008950:0.010079:0.005040:0.012891:0.014555:0.005604:0.010079:0.010079:0.010079:0.010079:0.015683:0.005040:0.005040
8:@0.401581:0.640910:0.407457:0.640910:0.407457:0.629716:0.401581:0.629716:0.005876
 College :@0.407457:0.647481:0.493152:0.647481:0.493152:0.628281:0.407457:0.628281:0.017941:0.013446:0.010079:0.005604:0.005604:0.008950:0.010079:0.008950:0.005040
of  Pharmacy,  Umm  Al-  Qura  University, :@0.104762:0.664585:0.493136:0.664585:0.493136:0.645385:0.104762:0.645385:0.010079:0.006713:0.005040:0.011241:0.011208:0.010079:0.008950:0.006713:0.015683:0.008950:0.008950:0.008761:0.005040:0.005040:0.011238:0.014555:0.015683:0.015683:0.005040:0.010124:0.014555:0.005604:0.006713:0.005040:0.011238:0.014555:0.010079:0.006713:0.008950:0.005040:0.011241:0.014555:0.010079:0.005604:0.010079:0.008950:0.006713:0.007842:0.005604:0.005604:0.008765:0.005040:0.005040
Makkah, Saudi Arabia,  Department of Clinical :@0.104762:0.681689:0.493154:0.681689:0.493154:0.662490:0.104762:0.662490:0.017921:0.008950:0.010079:0.010079:0.008950:0.010079:0.005040:0.005177:0.011208:0.008950:0.010079:0.010079:0.005604:0.004064:0.014555:0.006713:0.008950:0.010079:0.005604:0.008950:0.005040:0.005871:0.005181:0.014555:0.008950:0.010079:0.008950:0.006713:0.005604:0.015683:0.008950:0.010079:0.005604:0.005163:0.010079:0.006713:0.005181:0.013446:0.005604:0.005604:0.010079:0.005604:0.008950:0.008950:0.005604:0.005040
9:@0.290910:0.675118:0.296786:0.675118:0.296786:0.663925:0.290910:0.663925:0.005876
Pharmacy, Faculty of Pharmacy, University of :@0.104762:0.698794:0.493134:0.698794:0.493134:0.679594:0.104762:0.679594:0.011208:0.010079:0.008950:0.006713:0.015683:0.008950:0.008950:0.008761:0.005040:0.007102:0.011208:0.008950:0.008950:0.010079:0.005604:0.005604:0.010079:0.007092:0.010079:0.006713:0.007100:0.011208:0.010079:0.008950:0.006713:0.015683:0.008950:0.008950:0.008761:0.005040:0.007102:0.014555:0.010079:0.005604:0.010079:0.008950:0.006713:0.007842:0.005604:0.005604:0.010079:0.007094:0.010079:0.006713:0.005040
Sadat  City,  Sadat  City,  Egypt:@0.104762:0.715898:0.355996:0.715898:0.355996:0.696698:0.104762:0.696698:0.011208:0.008950:0.010079:0.008950:0.005604:0.005040:0.004100:0.013446:0.005604:0.005604:0.008763:0.005040:0.005040:0.004108:0.011208:0.008950:0.010079:0.008950:0.005604:0.005040:0.004100:0.013446:0.005604:0.005604:0.008763:0.005040:0.005040:0.004108:0.012317:0.010079:0.010079:0.010079:0.005604
Abstract:@0.104762:0.739737:0.174027:0.739737:0.174027:0.720651:0.104762:0.720651:0.013446:0.010079:0.006632:0.006632:0.007842:0.010079:0.008950:0.005604
Objectives::@0.104762:0.763575:0.196565:0.763575:0.196565:0.744489:0.104762:0.744489:0.014555:0.010079:0.005604:0.008950:0.008950:0.005604:0.005604:0.008950:0.008950:0.007842:0.006713
 Traumatic brain injury (TBI) is one :@0.196549:0.763575:0.493144:0.763575:0.493144:0.744375:0.196549:0.744375:0.004931:0.011605:0.006713:0.008950:0.010079:0.015683:0.008950:0.005604:0.005604:0.008950:0.005274:0.010079:0.006713:0.008950:0.005604:0.010079:0.005294:0.005604:0.010079:0.005604:0.010079:0.006713:0.010079:0.005290:0.006713:0.012317:0.013446:0.006713:0.006713:0.005292:0.005604:0.007842:0.005294:0.010079:0.010079:0.008950:0.005040
of  the  top  causes  of  morbidity  and  mortality :@0.104762:0.780679:0.493162:0.780679:0.493162:0.761480:0.104762:0.761480:0.010079:0.006713:0.005040:0.004137:0.005604:0.010079:0.008950:0.005040:0.004129:0.005604:0.010079:0.010079:0.005040:0.004133:0.008950:0.008950:0.010079:0.007842:0.008950:0.007842:0.005040:0.004139:0.010079:0.006713:0.005040:0.004137:0.015683:0.010079:0.006713:0.010079:0.005604:0.010079:0.005604:0.005604:0.010079:0.005040:0.004124:0.008950:0.010079:0.010079:0.005040:0.004133:0.015683:0.010079:0.006713:0.005604:0.008950:0.005604:0.005604:0.005604:0.010079:0.005040
worldwide.  The  review  aimed  to  discuss :@0.104762:0.797784:0.493132:0.797784:0.493132:0.778584:0.104762:0.778584:0.014555:0.010079:0.006713:0.005604:0.010079:0.014555:0.005604:0.010079:0.008950:0.005040:0.005040:0.011208:0.012317:0.010079:0.008950:0.005040:0.011571:0.006713:0.008950:0.010079:0.005604:0.008950:0.014555:0.005040:0.011569:0.008950:0.005604:0.015683:0.008950:0.010079:0.005040:0.011563:0.005604:0.010079:0.005040:0.011573:0.010079:0.005604:0.007842:0.008950:0.010079:0.007842:0.007842:0.005040
and  summarize  the  current  evidence  on  the :@0.104762:0.814888:0.493148:0.814888:0.493148:0.795688:0.104762:0.795688:0.008950:0.010079:0.010079:0.005040:0.006235:0.007842:0.010079:0.015683:0.015683:0.008950:0.006713:0.005594:0.008950:0.008950:0.005040:0.006231:0.005604:0.010079:0.008950:0.005040:0.006231:0.008950:0.010079:0.006713:0.006713:0.008950:0.010079:0.005604:0.005040:0.006235:0.008950:0.010079:0.005604:0.010079:0.008950:0.010079:0.008950:0.008950:0.005040:0.006221:0.010079:0.010079:0.005040:0.006239:0.005604:0.010079:0.008950:0.005040
effectiveness  of  adjuvant  neuroprotective :@0.104762:0.831992:0.493156:0.831992:0.493156:0.812793:0.104762:0.812793:0.008950:0.006088:0.006088:0.008950:0.008950:0.005604:0.005604:0.010079:0.008950:0.010079:0.008950:0.007842:0.007842:0.005040:0.017167:0.010079:0.006713:0.005040:0.017185:0.008950:0.010079:0.005604:0.010079:0.010079:0.008950:0.010079:0.005604:0.005040:0.017169:0.010079:0.008950:0.010079:0.006713:0.010079:0.010079:0.006713:0.010079:0.005604:0.008950:0.008950:0.005604:0.005604:0.010079:0.008950:0.005040
treatments in terms of their effect on brain injury :@0.104762:0.849097:0.493146:0.849097:0.493146:0.829897:0.104762:0.829897:0.005604:0.006713:0.008950:0.008950:0.005604:0.015683:0.008950:0.010079:0.005604:0.007842:0.003834:0.005604:0.010079:0.003848:0.005604:0.008950:0.006713:0.015683:0.007842:0.003850:0.010079:0.006713:0.003852:0.005604:0.010079:0.008950:0.005604:0.006713:0.003844:0.008950:0.006088:0.006088:0.008950:0.008950:0.005604:0.003840:0.010079:0.010079:0.003852:0.010079:0.006713:0.008950:0.005604:0.010079:0.003846:0.005604:0.010079:0.005604:0.010079:0.006713:0.010079:0.005040
biomarkers  in  TBI  patients.:@0.104762:0.866201:0.344665:0.866201:0.344665:0.847002:0.104762:0.847002:0.010079:0.005604:0.010079:0.015683:0.008950:0.006713:0.010079:0.008950:0.006713:0.007842:0.005040:0.006175:0.005604:0.010079:0.005040:0.005822:0.012317:0.013446:0.006713:0.005040:0.006181:0.010079:0.008950:0.005604:0.005604:0.008950:0.010079:0.005604:0.007842:0.005040
Methods::@0.104762:0.890039:0.183159:0.890039:0.183159:0.870954:0.104762:0.870954:0.017921:0.008950:0.005604:0.011208:0.010079:0.010079:0.007842:0.006713
  To  identify  relevant  studies,  four :@0.183162:0.890039:0.493141:0.890039:0.493141:0.870840:0.183162:0.870840:0.005040:0.007070:0.010906:0.010079:0.005040:0.007435:0.005604:0.010079:0.008950:0.010079:0.005604:0.005604:0.006713:0.010079:0.005040:0.007420:0.006713:0.008950:0.005604:0.008950:0.010079:0.008950:0.010079:0.005604:0.005040:0.007424:0.006572:0.006572:0.010079:0.010079:0.005604:0.008950:0.007842:0.005040:0.005040:0.007439:0.006713:0.010079:0.010079:0.006713:0.005040
scholarly :@0.104762:0.907144:0.183703:0.907144:0.183703:0.887944:0.104762:0.887944:0.007842:0.008950:0.010079:0.010079:0.005604:0.008950:0.006713:0.005604:0.010079:0.005040
databases, :@0.204539:0.907144:0.291867:0.907144:0.291867:0.887944:0.204539:0.887944:0.010079:0.008950:0.005604:0.008950:0.010079:0.008950:0.007842:0.008950:0.007842:0.005040:0.005040
including :@0.312703:0.907144:0.393902:0.907144:0.393902:0.887944:0.312703:0.887944:0.005604:0.010079:0.008950:0.005604:0.010079:0.010079:0.005604:0.010079:0.010079:0.005040
PubMed, :@0.414734:0.907144:0.493132:0.907144:0.493132:0.887944:0.414734:0.887944:0.011208:0.010079:0.010079:0.017921:0.008950:0.010079:0.005040:0.005040
Cochrane,  Scopus,  and  Google  Scholar,  were :@0.104762:0.924248:0.493138:0.924248:0.493138:0.905049:0.104762:0.905049:0.013446:0.010079:0.008950:0.010079:0.006713:0.008950:0.010079:0.008950:0.005040:0.005040:0.003820:0.011208:0.008950:0.010079:0.010079:0.010079:0.007842:0.005040:0.005040:0.003832:0.008950:0.010079:0.010079:0.005040:0.003826:0.014555:0.010079:0.010079:0.010079:0.005604:0.008950:0.005040:0.003828:0.011208:0.008950:0.010079:0.010079:0.005604:0.008950:0.005898:0.005040:0.005040:0.003830:0.014555:0.008950:0.006713:0.008950:0.005040
controlled  clinical  trials reporting changes :@0.511904:0.312666:0.900298:0.312666:0.900298:0.293466:0.511904:0.293466:0.008950:0.010079:0.010079:0.005604:0.006713:0.010079:0.005604:0.005604:0.008950:0.010079:0.005040:0.010733:0.008950:0.005604:0.005604:0.010079:0.005604:0.008950:0.008950:0.005604:0.005040:0.010733:0.005604:0.006713:0.005604:0.008950:0.005604:0.007842:0.015784:0.006713:0.008950:0.010079:0.010079:0.006713:0.005604:0.005604:0.010079:0.010079:0.015784:0.008950:0.010079:0.008950:0.010079:0.010079:0.008950:0.007842:0.005040
in  brain  injury  biomarkers,  namely,  neuron-:@0.511904:0.329770:0.895241:0.329770:0.895241:0.310571:0.511904:0.310571:0.005604:0.010079:0.005040:0.006277:0.010079:0.006713:0.008950:0.005604:0.010079:0.005040:0.006273:0.005604:0.010079:0.005604:0.010079:0.006713:0.010079:0.005040:0.006273:0.010079:0.005604:0.010079:0.015683:0.008950:0.006713:0.010079:0.008938:0.006713:0.007842:0.005040:0.005040:0.006283:0.010079:0.008950:0.015683:0.008950:0.005604:0.008757:0.005040:0.005040:0.006281:0.010079:0.008950:0.010079:0.006713:0.010079:0.010079:0.006713
specific  enolase  (NSE),  glial  fibrillary  acid :@0.511904:0.346875:0.900286:0.346875:0.900286:0.327675:0.511904:0.327675:0.007842:0.010079:0.008950:0.008950:0.005604:0.005604:0.005604:0.008950:0.005040:0.007916:0.008950:0.010079:0.010079:0.005604:0.008950:0.007842:0.008950:0.005040:0.007912:0.006713:0.014555:0.011208:0.012317:0.006713:0.005040:0.005040:0.007926:0.010079:0.005604:0.005604:0.008950:0.005604:0.005040:0.007908:0.005604:0.005604:0.010079:0.006713:0.005604:0.005604:0.005604:0.008950:0.006713:0.010079:0.005040:0.007912:0.008950:0.008950:0.005604:0.010079:0.005040
protein  (GFAP),  ubiquitin  carboxyl-terminal :@0.511904:0.363979:0.900302:0.363979:0.900302:0.344779:0.511904:0.344779:0.010079:0.006713:0.010079:0.005604:0.008950:0.005604:0.010079:0.005040:0.008457:0.006713:0.014555:0.009719:0.014555:0.011208:0.006713:0.005040:0.005040:0.008469:0.010079:0.010079:0.005604:0.010079:0.010079:0.005604:0.005604:0.005590:0.010079:0.005040:0.008467:0.008950:0.008950:0.006713:0.010079:0.010079:0.010079:0.010079:0.005604:0.006713:0.005604:0.008950:0.006713:0.015683:0.005604:0.010079:0.008950:0.005604:0.005040
esterase L1 (UCHL1) and/or S100 beta (S100 :@0.511904:0.381083:0.900274:0.381083:0.900274:0.361884:0.511904:0.361884:0.008950:0.006572:0.006572:0.008950:0.006713:0.008950:0.007842:0.008950:0.007394:0.012317:0.010079:0.007392:0.006713:0.014555:0.013446:0.014555:0.012317:0.010079:0.006713:0.007396:0.008950:0.010079:0.010079:0.005604:0.010079:0.006713:0.007394:0.011208:0.010079:0.010079:0.010079:0.007398:0.010079:0.008950:0.005604:0.008950:0.007386:0.006713:0.011208:0.010079:0.010079:0.010079:0.005040
ß), were included. The methodological quality :@0.511904:0.398188:0.900290:0.398188:0.900290:0.378988:0.511904:0.378988:0.010079:0.006713:0.005040:0.007104:0.014555:0.008950:0.006713:0.008950:0.007100:0.005604:0.010079:0.008950:0.005604:0.010079:0.010079:0.008950:0.010079:0.005040:0.006727:0.012317:0.010079:0.008950:0.007096:0.015683:0.008950:0.005604:0.010079:0.010079:0.010079:0.010079:0.005604:0.010079:0.010079:0.005604:0.008950:0.008950:0.005604:0.007078:0.010079:0.010079:0.008950:0.005604:0.005604:0.005604:0.010079:0.005040
of the included studies was assessed using the :@0.511904:0.415292:0.900284:0.415292:0.900284:0.396092:0.511904:0.396092:0.010079:0.006713:0.006977:0.005604:0.010079:0.008950:0.006969:0.005604:0.010079:0.008950:0.005604:0.010079:0.010079:0.008938:0.010079:0.006975:0.006572:0.006572:0.010079:0.010079:0.005604:0.008950:0.007842:0.006981:0.014555:0.008950:0.007842:0.006981:0.008950:0.007842:0.007842:0.008950:0.007842:0.007842:0.008950:0.010079:0.006979:0.010079:0.007842:0.005604:0.010079:0.010079:0.006977:0.005604:0.010079:0.008950:0.005040
Cochrane  risk-of-bias  tool.:@0.511904:0.432397:0.748598:0.432397:0.748598:0.413197:0.511904:0.413197:0.013446:0.010079:0.008950:0.010079:0.006713:0.008950:0.010079:0.008950:0.005040:0.010011:0.006713:0.005604:0.007842:0.010079:0.006713:0.010079:0.006713:0.006713:0.010079:0.005604:0.008950:0.007842:0.005040:0.010017:0.005604:0.010079:0.010079:0.005604:0.005040
Results::@0.511904:0.456235:0.579114:0.456235:0.579114:0.437149:0.511904:0.437149:0.013446:0.008950:0.007842:0.011208:0.005604:0.005604:0.007842:0.006713
  A  total  of  eleven  studies  with  eight :@0.579113:0.456235:0.900288:0.456235:0.900288:0.437035:0.579113:0.437035:0.005040:0.003379:0.013446:0.005040:0.004491:0.005604:0.010079:0.005604:0.008950:0.005604:0.005040:0.004481:0.010079:0.006713:0.005040:0.004491:0.008950:0.005604:0.008950:0.010079:0.008950:0.010067:0.005040:0.004491:0.006572:0.006572:0.010079:0.010079:0.005604:0.008950:0.007842:0.005040:0.004495:0.014555:0.005604:0.005604:0.010079:0.005040:0.004487:0.008950:0.005604:0.010079:0.010079:0.005604:0.005040
different therapeutic options were investigated; of :@0.511904:0.473339:0.900280:0.473339:0.900280:0.454140:0.511904:0.454140:0.010079:0.005604:0.006088:0.006088:0.008950:0.006713:0.008950:0.010079:0.005604:0.001510:0.005604:0.010079:0.008950:0.006713:0.008940:0.010079:0.008950:0.010079:0.005604:0.005604:0.008950:0.001510:0.010079:0.010079:0.005604:0.005604:0.010079:0.010079:0.007842:0.001522:0.014555:0.008950:0.006713:0.008950:0.001520:0.005604:0.010079:0.010079:0.008950:0.006572:0.006572:0.005604:0.010079:0.008950:0.005604:0.008950:0.010079:0.005604:0.001506:0.010079:0.006713:0.005040
them, tetracyclines, metformin, and memantine :@0.511904:0.490444:0.900308:0.490444:0.900308:0.471244:0.511904:0.471244:0.005604:0.010079:0.008950:0.015683:0.005040:0.005562:0.005604:0.008950:0.005604:0.006713:0.008950:0.008950:0.010079:0.008932:0.005604:0.005604:0.010079:0.008950:0.007842:0.005040:0.005564:0.015683:0.008950:0.005604:0.006713:0.010079:0.006713:0.015683:0.005604:0.010079:0.005040:0.005564:0.008950:0.010079:0.010079:0.005570:0.015683:0.008950:0.015683:0.008950:0.010079:0.005604:0.005604:0.010079:0.008950:0.005040
were  discovered  to  be  promising  choices  that :@0.511904:0.507548:0.900294:0.507548:0.900294:0.488348:0.511904:0.488348:0.014555:0.008950:0.006713:0.008950:0.005040:0.003244:0.010079:0.005604:0.007842:0.008950:0.010079:0.010079:0.008950:0.006713:0.008950:0.010079:0.005040:0.003244:0.005604:0.010079:0.005040:0.003242:0.010079:0.008950:0.005040:0.003244:0.010079:0.006713:0.010079:0.015683:0.005604:0.007842:0.005604:0.010079:0.010079:0.005040:0.003237:0.008950:0.010079:0.010079:0.005604:0.008950:0.008950:0.007842:0.005040:0.003235:0.005604:0.010079:0.008950:0.005604:0.005040
could  improve  neurological  outcomes  in  TBI :@0.511904:0.524652:0.900280:0.524652:0.900280:0.505453:0.511904:0.505453:0.008950:0.010079:0.010079:0.005604:0.010079:0.005040:0.004068:0.005604:0.015683:0.010079:0.006713:0.010079:0.010079:0.008950:0.005040:0.004064:0.010079:0.008950:0.010079:0.006713:0.010079:0.005604:0.010079:0.010079:0.005604:0.008950:0.008950:0.005604:0.005040:0.004054:0.010079:0.010079:0.005604:0.008950:0.010079:0.015683:0.008950:0.007842:0.005040:0.004064:0.005604:0.010079:0.005040:0.003705:0.012317:0.013446:0.006713:0.005040
patients.  The  most  utilized  serum  biomarkers :@0.511904:0.541757:0.900286:0.541757:0.900286:0.522557:0.511904:0.522557:0.010079:0.008950:0.005604:0.005604:0.008950:0.010079:0.005604:0.007842:0.005040:0.005040:0.003643:0.012317:0.010079:0.008950:0.005040:0.004014:0.015683:0.010079:0.006572:0.006572:0.005040:0.004026:0.010079:0.005604:0.005604:0.005604:0.005604:0.008950:0.008950:0.010079:0.005040:0.003999:0.007842:0.008950:0.006713:0.010079:0.015683:0.005040:0.004018:0.010079:0.005604:0.010079:0.015683:0.008950:0.006713:0.010079:0.008950:0.006713:0.007842:0.005040
were NSE and S100 ß followed by GFAP, while :@0.511904:0.558861:0.900290:0.558861:0.900290:0.539661:0.511904:0.539661:0.014555:0.008950:0.006713:0.008950:0.004497:0.014555:0.011208:0.012317:0.004499:0.008950:0.010079:0.010079:0.004499:0.011208:0.010079:0.010079:0.010079:0.004503:0.010079:0.004499:0.006713:0.010079:0.005604:0.005604:0.010079:0.014555:0.008950:0.010079:0.004501:0.010079:0.010079:0.004499:0.014555:0.009719:0.014555:0.008981:0.005040:0.004499:0.014555:0.010079:0.005604:0.005604:0.008950:0.005040
none of the included studies quantified UCHL1. :@0.511904:0.575966:0.900274:0.575966:0.900274:0.556766:0.511904:0.556766:0.010079:0.010079:0.010079:0.008950:0.004495:0.010079:0.006713:0.004499:0.005604:0.010079:0.008950:0.004491:0.005604:0.010079:0.008950:0.005604:0.010079:0.010079:0.008950:0.010079:0.004487:0.006572:0.006572:0.010079:0.010079:0.005604:0.008950:0.007842:0.004501:0.010079:0.010079:0.008950:0.010079:0.005604:0.005604:0.005604:0.005604:0.008950:0.010079:0.004489:0.014555:0.013446:0.014555:0.012317:0.010079:0.005040:0.005040
The heterogeneity in injury severity categories :@0.511904:0.593070:0.900300:0.593070:0.900300:0.573870:0.511904:0.573870:0.012317:0.010079:0.008950:0.006582:0.010079:0.008950:0.005604:0.008950:0.006713:0.010079:0.010079:0.008950:0.010067:0.008950:0.005604:0.005604:0.010079:0.006576:0.005604:0.010079:0.006586:0.005604:0.010079:0.005604:0.010079:0.006713:0.010079:0.006588:0.007842:0.008950:0.010079:0.008950:0.006713:0.005604:0.005604:0.010079:0.006578:0.008950:0.008950:0.005604:0.008950:0.010079:0.010079:0.006713:0.005604:0.008950:0.007842:0.005040
and measurement timing may affect the overall :@0.511904:0.610174:0.900304:0.610174:0.900304:0.590975:0.511904:0.590975:0.008950:0.010079:0.010079:0.005697:0.015683:0.008950:0.008950:0.007842:0.010079:0.006713:0.008950:0.015683:0.008950:0.010079:0.005604:0.005693:0.005604:0.005604:0.015683:0.005604:0.010079:0.010079:0.005685:0.015683:0.008950:0.010079:0.005695:0.008950:0.006088:0.006088:0.008950:0.008950:0.005604:0.005689:0.005604:0.010079:0.008950:0.005693:0.010079:0.010079:0.008950:0.006713:0.008950:0.005604:0.005604:0.005040
evaluation of the clinical efficacy of potential :@0.511904:0.627279:0.900296:0.627279:0.900296:0.608079:0.511904:0.608079:0.008950:0.010079:0.008950:0.005604:0.010079:0.008950:0.005604:0.005604:0.010079:0.010079:0.008039:0.010079:0.006713:0.008059:0.005604:0.010079:0.008950:0.008051:0.008950:0.005604:0.005604:0.010079:0.005604:0.008950:0.008950:0.005604:0.008035:0.008950:0.005691:0.005691:0.005691:0.008950:0.008950:0.008950:0.010079:0.008051:0.010079:0.006713:0.008057:0.010079:0.010079:0.005604:0.008950:0.010079:0.005604:0.005604:0.008950:0.005604:0.005040
therapies.  Therefore,  unified  measurement :@0.511904:0.644383:0.900296:0.644383:0.900296:0.625183:0.511904:0.625183:0.005604:0.010079:0.008950:0.006713:0.008950:0.010079:0.005604:0.008950:0.007842:0.005040:0.005040:0.013897:0.012317:0.010079:0.008950:0.006713:0.008950:0.006713:0.010079:0.006713:0.008950:0.005040:0.005040:0.014260:0.010079:0.010079:0.005604:0.005604:0.005604:0.008950:0.010079:0.005040:0.014270:0.015683:0.008950:0.008950:0.007842:0.010079:0.006713:0.008950:0.015683:0.008950:0.010079:0.005604:0.005040
protocols are highly warranted to inform clinical :@0.511904:0.661487:0.900302:0.661487:0.900302:0.642288:0.511904:0.642288:0.010079:0.006713:0.010079:0.005604:0.010079:0.008950:0.010079:0.005604:0.007842:0.003614:0.008950:0.006713:0.008950:0.003614:0.010079:0.005604:0.010079:0.010079:0.005604:0.010079:0.003614:0.014555:0.008950:0.006713:0.006713:0.008950:0.010079:0.005604:0.008950:0.010079:0.003614:0.005604:0.010079:0.003618:0.005604:0.010079:0.006713:0.010079:0.006713:0.015683:0.003614:0.008950:0.005604:0.005604:0.010079:0.005604:0.008950:0.008950:0.005604:0.005040
decisions.:@0.511904:0.678592:0.594333:0.678592:0.594333:0.659392:0.511904:0.659392:0.010341:0.009213:0.009213:0.005866:0.008104:0.005866:0.010341:0.010341:0.008104:0.005040
Conclusion::@0.511904:0.702430:0.613847:0.702430:0.613847:0.683344:0.511904:0.683344:0.013446:0.010079:0.011208:0.008950:0.005604:0.011208:0.007842:0.005604:0.010079:0.011208:0.006713
 :@0.613850:0.702430:0.618889:0.702430:0.618889:0.683230:0.613850:0.683230:0.005040
Few :@0.646438:0.702430:0.686191:0.702430:0.686191:0.683230:0.646438:0.683230:0.011208:0.008950:0.014555:0.005040
therapeutic :@0.713742:0.702430:0.808347:0.702430:0.808347:0.683230:0.713742:0.683230:0.005604:0.010079:0.008950:0.006713:0.008950:0.010079:0.008950:0.010079:0.005604:0.005604:0.008950:0.005040
options :@0.835874:0.702430:0.900281:0.702430:0.900281:0.683230:0.835874:0.683230:0.010079:0.010079:0.005604:0.005604:0.010079:0.010079:0.007842:0.005040
showed  promising  results  as  an  adjuvant  to :@0.511904:0.719534:0.900284:0.719534:0.900284:0.700335:0.511904:0.700335:0.007842:0.010079:0.010079:0.014555:0.008950:0.010079:0.005040:0.006038:0.010079:0.006713:0.010079:0.015683:0.005604:0.007842:0.005604:0.010079:0.010079:0.005040:0.006029:0.006713:0.008950:0.007842:0.010079:0.005604:0.005604:0.007842:0.005040:0.006034:0.008950:0.007842:0.005040:0.006034:0.008950:0.010079:0.005040:0.006031:0.008950:0.010079:0.005604:0.010079:0.010079:0.008950:0.010079:0.005604:0.005040:0.006021:0.005604:0.010079:0.005040
standard  care  in  patients  with  TBI.  Several :@0.511904:0.736639:0.900294:0.736639:0.900294:0.717439:0.511904:0.717439:0.006572:0.006572:0.008950:0.010079:0.010079:0.008950:0.006713:0.010079:0.005040:0.006622:0.008950:0.008950:0.006713:0.008950:0.005040:0.006620:0.005604:0.010079:0.005040:0.006618:0.010079:0.008950:0.005604:0.005604:0.008950:0.010079:0.005604:0.007842:0.005040:0.006610:0.014555:0.005604:0.005604:0.010079:0.005040:0.006253:0.012317:0.013446:0.006713:0.005040:0.005040:0.006618:0.011208:0.008950:0.010079:0.008950:0.006713:0.008950:0.005604:0.005040
considerations  for  future  work  must  be :@0.511904:0.753743:0.900280:0.753743:0.900280:0.734544:0.511904:0.734544:0.008950:0.010079:0.010079:0.007842:0.005604:0.010079:0.008950:0.006713:0.008950:0.005604:0.005604:0.010079:0.010079:0.007842:0.005040:0.014125:0.006713:0.010079:0.006713:0.005040:0.014137:0.006713:0.010079:0.005604:0.010079:0.006713:0.008950:0.005040:0.014131:0.014555:0.010079:0.006713:0.010079:0.005040:0.014139:0.015683:0.010079:0.006572:0.006572:0.005040:0.014141:0.010079:0.008950:0.005040
directed  towards  standardizing  monitoring :@0.511904:0.770848:0.900290:0.770848:0.900290:0.751648:0.511904:0.751648:0.010079:0.005604:0.006713:0.008950:0.008950:0.005604:0.008950:0.010079:0.005040:0.013845:0.005604:0.010079:0.014555:0.008950:0.006713:0.010079:0.007842:0.005040:0.013859:0.006572:0.006572:0.008950:0.010079:0.010079:0.008950:0.006713:0.010079:0.005604:0.008950:0.005604:0.010079:0.010079:0.005040:0.013851:0.015683:0.010079:0.010079:0.005604:0.005604:0.010079:0.006713:0.005604:0.010079:0.010079:0.005040
biomarkers. Investigating the pharmacotherapy :@0.511904:0.787952:0.900302:0.787952:0.900302:0.768752:0.511904:0.768752:0.010079:0.005604:0.010079:0.015683:0.008950:0.006713:0.010079:0.008950:0.006713:0.007842:0.005040:0.006025:0.006713:0.010079:0.010079:0.008950:0.006572:0.006572:0.005604:0.010079:0.008950:0.005604:0.005604:0.010079:0.010079:0.006025:0.005604:0.010079:0.008950:0.006031:0.010079:0.010079:0.008950:0.006713:0.015683:0.008950:0.008950:0.010079:0.005604:0.010079:0.008950:0.006713:0.008950:0.010079:0.010079:0.005040
effectiveness  using  a  multimodal  biomarker :@0.511904:0.805056:0.900294:0.805056:0.900294:0.785857:0.511904:0.785857:0.008950:0.006088:0.006088:0.008950:0.008950:0.005604:0.005604:0.010079:0.008950:0.010079:0.008950:0.007842:0.007842:0.005040:0.007682:0.010079:0.007842:0.005604:0.010079:0.010079:0.005040:0.007699:0.008950:0.005040:0.007695:0.015683:0.010079:0.005604:0.005604:0.005604:0.015683:0.010079:0.010079:0.008950:0.005604:0.005040:0.007678:0.010079:0.005604:0.010079:0.015683:0.008950:0.006713:0.010079:0.008950:0.006713:0.005040
panel  is  needed.  Finally,  employing  stratified :@0.511904:0.822161:0.900280:0.822161:0.900280:0.802961:0.511904:0.802961:0.010079:0.008950:0.010079:0.008950:0.005604:0.005040:0.004308:0.005604:0.007842:0.005040:0.004318:0.010079:0.008950:0.008950:0.010079:0.008950:0.010079:0.005040:0.005040:0.004308:0.011208:0.005604:0.010079:0.008950:0.005604:0.005604:0.008761:0.005040:0.005040:0.004318:0.008950:0.015683:0.010079:0.005604:0.010079:0.010079:0.005604:0.010079:0.010079:0.005040:0.004304:0.006572:0.006572:0.006713:0.008950:0.005604:0.005604:0.005604:0.005604:0.008950:0.010079:0.005040
randomization in future clinical trials concerning :@0.511904:0.839265:0.900290:0.839265:0.900290:0.820065:0.511904:0.820065:0.006713:0.008950:0.010079:0.010079:0.010079:0.015683:0.005604:0.008950:0.008950:0.005604:0.005604:0.010079:0.010079:0.002758:0.005604:0.010079:0.002776:0.006713:0.010079:0.005604:0.010079:0.006713:0.008950:0.002776:0.008950:0.005604:0.005604:0.010079:0.005604:0.008950:0.008950:0.005604:0.002756:0.005604:0.006713:0.005604:0.008950:0.005604:0.007842:0.002772:0.008950:0.010079:0.010079:0.008950:0.008950:0.006713:0.010079:0.005604:0.010079:0.010079:0.005040
potential  confounders,  including  age,  trauma :@0.511904:0.856369:0.900298:0.856369:0.900298:0.837170:0.511904:0.837170:0.010079:0.010079:0.005604:0.008950:0.010079:0.005604:0.005604:0.008950:0.005604:0.005040:0.005687:0.008950:0.010079:0.010079:0.006713:0.010079:0.010079:0.010079:0.010079:0.008950:0.006713:0.007842:0.005040:0.005040:0.005707:0.005604:0.010079:0.008950:0.005604:0.010079:0.010079:0.005604:0.010079:0.010079:0.005040:0.005701:0.008950:0.010079:0.008950:0.005040:0.005040:0.005701:0.005604:0.006713:0.008950:0.010079:0.015683:0.008950:0.005040
severity  levels,  and  type,  is  crucial  to  inform :@0.511904:0.873474:0.900284:0.873474:0.900284:0.854274:0.511904:0.854274:0.007842:0.008950:0.010079:0.008950:0.006713:0.005604:0.005604:0.010079:0.005040:0.003491:0.005604:0.008950:0.010079:0.008950:0.005604:0.007842:0.005040:0.005040:0.003489:0.008950:0.010079:0.010079:0.005040:0.003498:0.005604:0.010079:0.010079:0.008950:0.005040:0.005040:0.003494:0.005604:0.007842:0.005040:0.003502:0.008950:0.006713:0.010079:0.008950:0.005604:0.008950:0.005604:0.005040:0.003483:0.005604:0.010079:0.005040:0.003498:0.005604:0.010079:0.006713:0.010079:0.006713:0.015683:0.005040
clinical:@0.511904:0.890578:0.571252:0.890578:0.571252:0.871379:0.511904:0.871379:0.008950:0.005604:0.005604:0.010079:0.005604:0.008950:0.008950:0.005604
decisions.:@0.598186:0.890578:0.678256:0.890578:0.678256:0.871379:0.598186:0.871379:0.010079:0.008950:0.008950:0.005604:0.007842:0.005604:0.010079:0.010079:0.007842:0.005040
https://doi.org/10.3389/:@0.705206:0.890578:0.895244:0.890578:0.895244:0.871379:0.705206:0.871379:0.010079:0.005604:0.005604:0.010079:0.007842:0.005604:0.005604:0.005604:0.010079:0.010079:0.005604:0.005040:0.010079:0.006332:0.010079:0.005604:0.010079:0.010079:0.005040:0.010079:0.010079:0.010079:0.010079:0.005604
fphar.2023.1185277:@0.511904:0.907683:0.689995:0.907683:0.689995:0.888483:0.511904:0.888483:0.007680:0.011047:0.011047:0.009918:0.006576:0.006007:0.011047:0.011047:0.011047:0.011047:0.006007:0.010305:0.011047:0.011047:0.011047:0.011047:0.011047:0.010079